Safety and efficacy trial of caspofungin versus fluconazole for the treatment of invasive fungal infection in high-risk liver transplant patients

Trial Profile

Safety and efficacy trial of caspofungin versus fluconazole for the treatment of invasive fungal infection in high-risk liver transplant patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jan 2016

At a glance

  • Drugs Caspofungin (Primary) ; Fluconazole
  • Indications Mycoses
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jan 2016 New trial record
    • 28 Dec 2015 Results published in the Liver Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top